Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
26 Février 2019 - 2:30PM
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical
device company, announced today that Fred Parks, PhD, Chief
Executive Officer, and Walter Berger, Chief Operating Officer &
Chief Financial Officer, are scheduled to present at the upcoming
39th Annual Cowen Healthcare Conference in Boston, Massachusetts.
Event:
39th Annual Cowen Healthcare
ConferenceDate:
Tuesday, March 12,
2019Time:
11:20am
ETFormat:
Presentation and 1x1s
meetingsLocation:
Boston Marriott Copley Place, Boston, MA
Webcasts of the Company’s fireside chats will be
available by visiting the investor relations section of Nuvectra’s
website at www.nuvectramed.com. Webcast replays of the
presentations will be available for 90 days.
About Nuvectra Corporation
Nuvectra® is a neurostimulation company committed to helping
physicians improve the lives of people with chronic conditions. The
Algovita® Spinal Cord Stimulation (SCS) System is our first
commercial offering and is CE marked and FDA approved for the
treatment of chronic intractable pain of the trunk and/or limbs.
Our innovative technology platform also has capabilities under
development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. Visit the Nuvectra website at www.nuvectramed.com.
Company
Contacts:
Investor Contacts:Nuvectra
Corporation
The Ruth
Group
Walter Berger, COO & CFO
Tram Bui /
Brian Johnston(214)
474-3102
(646) 536-7035 /
7028
wberger@nuvectramed.com
investors@nuvectramed.com
Nuvectra (NASDAQ:NVTR)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Nuvectra (NASDAQ:NVTR)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Nuvectra Corporation (NASDAQ): 0 recent articles
Plus d'articles sur